A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Report on how AI is redefining market landscape - The global gastroparesis drugs market  size is estimated to grow by USD 1.42 billion from 2024-2028, according to Technavio. The market is estimated ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

However, as for traditional chemotherapy, ADCs can also induce treatment resistance and side effects such as neuropathy.

"Access to the PSPP program will advance our understanding and development of ART26.12,” commented Saoirse O'Sullivan, PhD, ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

As the disease progresses, patients lose the ability to talk, walk, swallow and concentrate. Most patients die within 10 to 20 years after symptoms first appear. The new treatment leverages ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments. One of these, lecanemab ...

Patients with Huntington’s disease have a genetic mutation that triggers proteins to misfold and clump together in the brain.

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an ...